Sergiu Pasca

Mr. Sergiu Pasca

University of Medicine and Pharmacy "Iuliu Hatieganu"

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2015 in Nature Methods
Verified
Journal Article
Closed access
PDF file
APAnca M Paşca
Anca M Paşca
SSSteven A Sloan
Steven A Sloan
LCLaura E Clarke
Laura E Clarke
YTYuan Tian
Yuan Tian
CMChristopher D Makinson
Christopher D Makinson
Sergiu PascaSergiu Pasca
Sergiu Pasca

26 April 2017 in Nature
Verified
Journal Article
Open access
PDF file
FBFikri Birey
Fikri Birey
JAJimena Andersen
Jimena Andersen
CMChristopher D. Makinson
Christopher D. Makinson
SISaiful Islam
Saiful Islam
WWWu Wei
Wu Wei
Sergiu PascaSergiu Pasca
Sergiu Pasca
The development of the nervous system involves a coordinated succession of events including the migration of GABAergic (γ-aminobutyric-acid-releasing) neurons from ventral to dorsal forebrain and their integration into cortical circuits. However, these interregional interactions have not yet been modelled with human cells. Here we generate three-dimensional spheroids from human pluripotent stem cells that resemble either the dorsal or ventral forebrain and contain cortical glutamatergic or GABAergic neurons. These subdomain-specific forebrain spheroids can be assembled in vitro to recapitulate the saltatory migration of interneurons observed in the fetal forebrain. Using this system, we find that in Timothy syndrome—a neurodevelopmental disorder that is caused by mutations in the CaV1.2 calcium channel—interneurons display abnormal migratory saltations. We also show that after migration, interneurons functionally integrate with glutamatergic neurons to form a microphysiological system. We anticipate that this approach will be useful for studying neural development and disease, and for deriving spheroids that resemble other brain regions to assemble circuits in vitro.

1 February 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
BDBenjamin E Deverman
Benjamin E Deverman
PPPiers L Pravdo
Piers L Pravdo
BSBryan P Simpson
Bryan P Simpson
SKSripriya Ravindra Kumar
Sripriya Ravindra Kumar
KCKen Y Chan
Ken Y Chan
VGViviana Gradinaru
Viviana Gradinaru

16 December 2020 in Cell
Verified
Journal Article
Closed access
JAJimena Andersen
Jimena Andersen
OROmer Revah
Omer Revah
YMYuki Miura
Yuki Miura
NTNicholas Thom
Nicholas Thom
NANeal D. Amin
Neal D. Amin
Sergiu PascaSergiu Pasca
Sergiu Pasca

1 August 2017 in Neuron
Verified
Journal Article
Closed access
SSSteven A. Sloan
Steven A. Sloan
SDSpyros Darmanis
Spyros Darmanis
NHNina Huber
Nina Huber
TKThemasap A. Khan
Themasap A. Khan
FBFikri Birey
Fikri Birey
Sergiu PascaSergiu Pasca
Sergiu Pasca

27 November 2011 in Nature Medicine
Verified
Journal Article
Open access
PDF file
Sergiu PascaSergiu Pasca
Sergiu Pasca
TPThomas Portmann
Thomas Portmann
IVIrina Voineagu
Irina Voineagu
MYMasayuki Yazawa
Masayuki Yazawa
ASAleksandr Shcheglovitov
Aleksandr Shcheglovitov
RDRicardo E Dolmetsch
Ricardo E Dolmetsch
Timothy syndrome is a neurodevelopmental disease that includes autism-like features. Using iPS-derived neurons from individuals with Timothy syndrome, Ricardo Dolmetsch and his colleagues identify changes in cortical neuron fate and neurotransmitter expression that may begin to explain the neural mechanisms that underlie this disorder. Monogenic neurodevelopmental disorders provide key insights into the pathogenesis of disease and help us understand how specific genes control the development of the human brain. Timothy syndrome is caused by a missense mutation in the L-type calcium channel Cav1.2 that is associated with developmental delay and autism1. We generated cortical neuronal precursor cells and neurons from induced pluripotent stem cells derived from individuals with Timothy syndrome. Cells from these individuals have defects in calcium (Ca2+) signaling and activity-dependent gene expression. They also show abnormalities in differentiation, including decreased expression of genes that are expressed in lower cortical layers and in callosal projection neurons. In addition, neurons derived from individuals with Timothy syndrome show abnormal expression of tyrosine hydroxylase and increased production of norepinephrine and dopamine. This phenotype can be reversed by treatment with roscovitine, a cyclin-dependent kinase inhibitor and atypical L-type–channel blocker2,3,4. These findings provide strong evidence that Cav1.2 regulates the differentiation of cortical neurons in humans and offer new insights into the causes of autism in individuals with Timothy syndrome.